Mike McMullen vs Prahlad Singh

Mike McMullen

CEO of Agilent Technologies

BIO: Mike McMullen was appointed Agilent CEO in March 2015, replacing William (Bill) Sullivan. McMullen has more than 30 years of industry experience and senior management experience at Agilent. He was president of the company's Chemical Analysis Group from 2009 until November 2014. As head of CAG, McMullen transformed the business, consistently delivering market-leading growth and profits. He championed strategic acquisitions and architected Agilent's China strategy. He built the Agilent CrossLab Group, which includes services, software and consumables; ACG was made one of Agilent's three major businesses in September 2014. McMullen also has significant international experience, having lived in Japan, where he led Agilent's Japan field sales and support operations, later adding responsibility for China field operations. He is recognized for his inspirational leadership style. McMullen joined Agilent's predecessor, Hewlett-Packard Co., in 1984 as a financial analyst. He holds a bachelor's degree in economics and business administration from the University of Delaware and an MBA from the Wharton School of Business. McMullen also serves on the Board of Directors for Coherent, Inc.

Prahlad Singh

CEO of PerkinElmer

BIO: Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. He also currently serves on the Board of Directors of the Analytical, Life Science & Diagnostics Association (ALDA). Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world